Skip to main content

Renal Denervation Topic Center

Featured

renal denervation
11/04/2024
CMS has granted transitional pass-through (TPT) payment for the Medtronic Symplicity Spyral™ renal denervation catheter, used in the Symplicity™ blood pressure procedure, under the Medicare Hospital Outpatient Prospective Payment System. TPT...
CMS has granted transitional pass-through (TPT) payment for the Medtronic Symplicity Spyral™ renal denervation catheter, used in the Symplicity™ blood pressure procedure, under the Medicare Hospital Outpatient Prospective Payment System. TPT...
CMS has granted transitional...
11/04/2024
Cath Lab Digest
Renal denervation
10/29/2024
"These findings are a key step toward informing the medical community of the long-term effectiveness with radiofrequency renal denervation as a treatment for uncontrolled hypertension," stated Dr. David Kandzari.
"These findings are a key step toward informing the medical community of the long-term effectiveness with radiofrequency renal denervation as a treatment for uncontrolled hypertension," stated Dr. David Kandzari.
"These findings are a key step...
10/29/2024
Cath Lab Digest
ESC 2024
08/30/2024
Medtronic News Medtronic is encouraged by the new the European Society of Cardiology (ESC) 2024 guidelines, which upgraded renal denervation (RDN) as a class IIb recommendation, providing a safe and effective complementary care option for...
Medtronic News Medtronic is encouraged by the new the European Society of Cardiology (ESC) 2024 guidelines, which upgraded renal denervation (RDN) as a class IIb recommendation, providing a safe and effective complementary care option for...
Medtronic News Medtronic is...
08/30/2024
Cath Lab Digest
CMS
08/13/2024
CMS posted its FY25 Inpatient Prospective Payment System (IPPS) Final Rule, which covers the New Technology Add-on Payment (NTAP) program.  In the final rule, CMS approved NTAP for the Symplicity Spyral™ catheter. The NTAP will go into effect...
CMS posted its FY25 Inpatient Prospective Payment System (IPPS) Final Rule, which covers the New Technology Add-on Payment (NTAP) program.  In the final rule, CMS approved NTAP for the Symplicity Spyral™ catheter. The NTAP will go into effect...
CMS posted its FY25 Inpatient...
08/13/2024
Cath Lab Digest
CMS
08/13/2024
CMS approved a New Technology Add-On Payment (NTAP) for the Paradise™ Ultrasound Renal Denervation (uRDN) system when performed in the hospital inpatient setting. Availability of the NTAP will begin on October 1, 2024, using the ICD-10-PCS...
CMS approved a New Technology Add-On Payment (NTAP) for the Paradise™ Ultrasound Renal Denervation (uRDN) system when performed in the hospital inpatient setting. Availability of the NTAP will begin on October 1, 2024, using the ICD-10-PCS...
CMS approved a New Technology...
08/13/2024
Cath Lab Digest
Real-World Studies
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Cutting-Edge Procedures
05/01/2024

Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

Director, Vascular Intervention, Beth Israel Deaconess Medical Center; Section Head, Interventional Cardiology and Vascular Research, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center; Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts

 

Disclosures: Dr. Secemsky reports he is a consultant to Medtronic and his institution receives funding from Medtronic.

 

Eric A. Secemsky, MD, MSc, RPVI, FACC...
We have struggled for years with managing hypertension. In my own practice, I recognized that I only had so many tools to offer my patients, primarily medical therapy and suggestions on lifestyle changes. However, there were still patients...
We have struggled for years with managing hypertension. In my own practice, I recognized that I only had so many tools to offer my patients, primarily medical therapy and suggestions on lifestyle changes. However, there were still patients...
We have struggled for years with...
05/01/2024
Cath Lab Digest
Clinical Images
03/22/2024

Ariana Gonzálvez-García, MD; Alfonso Jurado-Román, MD, PhD; Daniel Tébar-Márquez, MD; Santiago Jiménez-Valero, MD; Guillermo Galeote, MD, PhD; Borja Rivero-Santana, MD; Raúl Moreno, MD, PhD

Ariana Gonzálvez-García, MD; Alfonso ...
The authors describe the role of dynamic road-mapping for renal denervation.
The authors describe the role of dynamic road-mapping for renal denervation.
The authors describe the role of...
03/22/2024
Journal of Invasive Cardiology
From Journal of Invasive Cardiology
New Devices
12/04/2023

Medtronic News

Medtronic News
The procedure is approved for use as an adjunctive treatment in patients with hypertension when lifestyle changes and medications do not adequately control blood pressure.
The procedure is approved for use as an adjunctive treatment in patients with hypertension when lifestyle changes and medications do not adequately control blood pressure.
The procedure is approved for...
12/04/2023
Cath Lab Digest
Michael J. Bloch headshot
Meeting Update
11/22/2023
Michael J. Bloch, MD, discusses hypertension and a patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials.
Michael J. Bloch, MD, discusses hypertension and a patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials.
Michael J. Bloch, MD, discusses...
11/22/2023
Journal of Invasive Cardiology
From Journal of Invasive Cardiology
FDA Approval
11/20/2023

Medtronic News

Medtronic News
Manufacturing of the device for U.S. distribution is already underway, and Medtronic hopes to make it widely available soon to physicians and healthcare systems.
Manufacturing of the device for U.S. distribution is already underway, and Medtronic hopes to make it widely available soon to physicians and healthcare systems.
Manufacturing of the device for...
11/20/2023
Cath Lab Digest